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Abstract
The endoplasmic reticulum (ER) is involved in several crucial cellular functions, e.g. protein folding
and quality control, maintenance of Ca2+ balance, and cholesterol synthesis. Many genetic and
environmental insults can disturb the function of ER and induce ER stress. ER contains three
branches of stress sensors, i.e. IRE1, PERK and ATF6 transducers, which recognize the misfolding
of proteins in ER and activate a complex signaling network to generate the unfolded protein
response (UPR). Alzheimer's disease (AD) is a progressive neurodegenerative disorder involving
misfolding and aggregation of proteins in conjunction with prolonged cellular stress, e.g. in redox
regulation and Ca2+ homeostasis. Emerging evidence indicates that the UPR is activated in neurons
but not in glial cells in AD brains. Neurons display pPERK, peIF2α and pIRE1α immunostaining along
with abundant diffuse staining of phosphorylated tau protein. Recent studies have demonstrated
that ER stress can also induce an inflammatory response via different UPR transducers. The most
potent pathways are IRE1-TRAF2, PERK-eIF2α, PERK-GSK-3, ATF6-CREBH, as well as
inflammatory caspase-induced signaling pathways. We will describe the mechanisms which could
link the ER stress of neurons to the activation of the inflammatory response and the evolution of
pathological changes in AD.
Introduction
Alzheimer's disease (AD) is a progressive neurodegenera-
tive disorder involving a gradual decline in many cogni-
tive processes ultimately leading to dementia.
Accumulation of β-amyloid plaques and neurofibrillary
tangles are the well-known histopathological hallmarks of
AD [1,2]. It is recognized that increased production, oli-
gomerization and aggregation of amyloid-β peptides are
the crucial factors in the onset of AD. The toxic amyloid-β
peptides Aβ40 and Aβ42 are processed from the APP
(amyloid-β precursor protein) via cleavage by BACE1 (β-
secretase) and γ-secretase complexes [1,3,4]. APP is a
transmembrane protein which is folded and modified in
endoplasmic reticulum (ER) and transported through the
Golgi complex to the outer membrane. Once on cell sur-
face, APP can be endocytosed and transported to the lyso-
somal compartment. In the brain, APP is expressed
mainly in neurons but astrocytes and oligodendrocytes
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can also express and process APP protein. Currently, it is
not clear which cellular compartment processes APP to
the toxic amyloid-β peptides [3]. It seems that the process-
ing can occur in different compartments during transport
from the ER to lysosomes depending on the cellular cir-
cumstances, e.g. metabolism and stress conditions.
Apparently, oligomerization of amyloid-β peptides is
important since several studies have demonstrated that
oligomers and fibrils are the toxic forms of amyloid-β
peptides [5]. A number of studies have demonstrated that
amyloid-β can be oligomerized and localized to intracel-
lular compartments, in particular in AD [3], which can (i)
disturb the function of proteasomes and lysosomes, (ii)
impair calcium homeostasis and (iii) enhance the forma-
tion of neurofibrillary tangles in neurons (see below).
Accumulation of unfolded or aggregated proteins,
increased oxidative stress, and metabolic disturbances are
characteristic features of AD [1,3]. ER is a sensitive
organelle which can recognize disturbances in cellular
homeostasis and therefore it is not surprising that AD
brains display many indications of ER stress [6]. ER can
defend the host by activating the UPR (unfolded protein
response) including signaling cascades that evoke the
adaptive changes in metabolism and gene expression
required to manage stress situations. Should a condition
become more prolonged or overwhelming, the ER can
then trigger the apoptotic program killing the cell but sav-
ing the tissue from necrotic injury. Interestingly, recent
studies have demonstrated that ER stress can also elicit an
innate immunity defence to protect tissues [7]. Currently,
it is known that cellular stress triggers the innate immu-
nity system by sending alarming signals, i.e. alarmins [8],
or by activating the recognition receptors of inflammas-
omes [9]. Inflammation is a crucial event in the pathogen-
esis of AD, but its cause and role in AD pathogenesis are
still controversial [e.g. [10]]. We will describe here the
mechanisms which could link ER stress in neurons to acti-
vation of inflammatory responses and to the pathological
changes observed in AD.
ER stress and UPR signaling
The ER is a membrane-enclosed reticular network con-
necting the nuclear envelope to the Golgi complex [11]. It
has multiple vital functions: (i) protein folding, post-
translational modification, and transport to the Golgi
complex, (ii) maintenance of cellular calcium homeosta-
sis, (iii) synthesis of lipids and sterols, and (iv) regulation
of cellular survival via a complex transducer and signaling
network [11-16]. ER is a sensitive sensor of cellular home-
ostasis and different types of insults, e.g. proteasomal
inhibition and impaired redox regulation and calcium
balance, can disturb the function of ER and induce ER
stress (Figure 1). ER stress involves the accumulation of
unfolded and deficiently modified proteins, disturbances
in lipid metabolism, and release of ER luminal Ca2+ into
the cytoplasm [12,13]. In particular, failure of protein
quality control is detrimental to cellular survival and
therefore ER can trigger an evolutionarily conserved UPR
to counteract the situation [13-16].
During the last ten years, different branches of ER stress
transducers have been identified and recently reviewed in
detail [13-16]. Unfolded proteins are recognized in ER via
three classes of sensors, (i) IRE1 (inositol-requiring pro-
tein-1), (ii) PERK (protein kinase RNA-like ER kinase),
and (iii) ATF6 (activating transcription factor-6) (Figure
1). The activation mechanism of these proteins has not
been totally resolved but it is known that certain molecu-
lar chaperones of ER lumen, e.g. BiP (Grp78), are involved
in the activation of these transmembrane transducers. The
proteins' cytoplasmic domains trigger the specific protein
kinase responses or activate transcription factors which
can induce the expression of hundreds of target genes.
This defence response is called UPR and consists of several
chaperone proteins and the proteins of antiapoptotic and
antioxidative system. Excessive and prolonged ER stress
can ultimately activate apoptotic cell death (Figure 1).
The activation of the IRE1 pathway triggers the dimeriza-
tion of IRE1α proteins which stimulates the cytoplasmic
kinase domains and subsequently the endoribonuclease
domains of the IRE1α transducer [15,16] (Figure 1). The
mRNA of XBP1 (X-box binding protein-1) is the only
known substrate of the IRE1α endoribonuclease. IRE1α
cleaves off one intron from XBP1 mRNA which activates
the synthesis of XBP1 protein. XBP1 encodes the tran-
scription factor that trans-activates expression of several
UPR target genes. In addition, activated IRE1α can bind
TRAF2 protein (tumor necrosis factor receptor-associated
factor 2) which subsequently stimulates stress-kinases,
e.g. JNK (c-Jun N-terminal kinase) [16-18], and in this
way triggers apoptotic cell death [19] (Figure 1).
The lumenal domain of PERK protein is homologous to
that of IRE1α, but the cytoplasmic kinase domain can
phosphorylate the α-subunit of eIF2α (eukaryotic transla-
tion initiation factor-2) [15,16] (Figure 1). The phospho-
rylation of eIF2α protein inhibits the initiation of
translation and in this way can alleviate ER stress by
reducing the amount of protein transport into the ER.
However, some stress-related mRNAs contain upstream
sequences that can elevate translational efficiency in asso-
ciation with eIF2α phosphorylation during ER stress.
ATF4 (activating transcription factor 4) is one of these
mRNAs and the expression of ATF protein increases not
only during ER stress but also in response to many other
insults, e.g. hypoxia [20]. ATF4 expression can activate not
only a variety of UPR genes but also genes involved in
angiogenesis and autophagy [20]. Phosphorylation ofJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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eIF2α can also increase the expression of BACE1 via the
unique upstream sequences in BACE1 mRNA [21].
The third branch of ER stress transducers includes the
ATF6 protein and ATF-related proteins such as the bZIP
transmembrane family [22] (Figure 1). Other family
members are CREBH, which is expressed only in liver,
OASIS, present in astrocytes, and BBF2H7, found in sev-
eral tissues, e.g. neurons [22,23]. ER stress evokes the
translocation of ATF6 molecules from the ER to the Golgi
complex where S2P (site 2 protease) cleaves off the cyto-
plasmic domain which is a bZIP transcription factor. This
factor is then transferred to the nucleus where it transacti-
vates a set of UPR genes [22]. There are two ATF6 iso-
forms, ATF6α and ATF6β, which have opposite effects, i.e.
ATF6β is a transcriptional repressor protein balancing the
effect of ATF6α protein [24]. Although the functions of
ATF6 branch of ER stress transducers are largely unknown,
it seems that ATF6 can activate the expression of only a
few UPR genes indicating that ATF6 may have functions
other than those related to UPR. Doroudgar et al. [25]
observed that ischemia is a sensitive inducer of the ATF6
branch of ER stress responses. Several studies have indi-
cated that the ATF6 family of ER stress transducers can be
highly specific with respect to stress signals and the expres-
sion pattern of target genes in different tissues [22].
The ER, along with mitochondria, is an important
organelle in the regulation of cellular Ca2+ homeostasis
[12]. ER is a dynamic Ca2+ store that can quickly trigger
intracellular Ca2+ signals but that also can serve as a Ca2+
buffer by removing excessive Ca2+ ions from the cyto-
plasm. In addition, several ER chaperones and foldases
are Ca2+-binding proteins. This folding of proteins
requires an oxidizing environment, but oxidative stress
itself can induce ER stress and Ca2+ release from the ER
[12]. Disturbances in Ca2+ regulation of ER are generally
associated with ER stress, and the impaired cross talk
between ER and mitochondria is a key component lead-
ing to apoptosis [16,26]. A large body of evidence has
demonstrated that the Bcl-2 (B-cell lymphoma protein 2)
family of antiapoptotic proteins can inhibit Ca2+ release
from ER in times of cellular stress, leading to apoptosis
triggered by mitochondria [16,26]. Increased intracellular
Ca2+ concentrations can activate several signal pathways,
e.g. calpains, calcineurin and phospholipases, which are
related not only to apoptosis but also to a variety of phys-
iological and pathological functions [16]. Interestingly, a
number of studies have demonstrated that ER stress can
activate NF-κB signaling following Ca2+ release from the
ER and subsequent ROS (reactive oxygen species) produc-
tion, e.g. in mitochondria [27].
ER stress in Alzheimer's disease
Neurons are vulnerable to different genetic and environ-
mental insults which affect the homeostasis of ER func-
tion via the accumulation of unfolded proteins and
disturbances in redox and Ca2+ balances. Therefore, it is
not surprising that a number of studies have demon-
strated that ER stress is present in several neurodegenera-
tive diseases [28-30]. Evidence of activated UPR signaling
has been detected in Alzheimer's, Parkinson's and Hunt-
A schematic presentation of the three branches of UPR, their signaling pathways, and pathological responses with respect to  inflammation and AD pathology Figure 1
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ington's diseases, and in ALS (amyotrophic lateral sclero-
sis) [6,28-32]. Furthermore, cerebral ischemia can trigger
the UPR, although a concommitant drastic decline in pro-
tein synthesis clearly decreases the level of UPR [33]. Viral
infections, e.g. Borna virus, can induce prominent ER
stress in neurons and subsequently stimulate UPR signal-
ing [34]. In neurons, the tubules and cisternae of ER can
extend from the nuclear envelope into dendrites and den-
dritic spines, and also along axons as far as presynaptic
terminals. This means that the neuronal ER is a very spe-
cialized organ with functionally different subcompart-
ments [35,36]. For example, Murakami et al. [37] revealed
that the ER stress response can be localized to dendrites.
This heterogeneity of the ER network in neurons may be
related to synaptic loss and axonal degeneration [38], par-
ticularly in the case of redox-based dysfunctions [36].
Kudo et al. [39] demonstrated that a chemical inducer of
BiP chaperone expression could prevent neuronal death
in both in vitro and in vivo conditions, emphasizing a role
for ER stress in neuronal degeneration.
A large body of evidence indicates that the accumulation
of intracellular amyloid-β and phosphorylated tau pro-
teins, along with the perturbation of Ca2+ homeostasis,
plays a prominent role in the pathogenesis of AD [1,3,40].
Recently, Hoozemans et al. [41] described in detail the
changes in neuronal UPR in the brains of AD patients.
They observed that immunohistochemical staining of
phosphorylated (activated) UPR kinases, pPERK, peIF2α
and pIRE1α, was clearly increased in hippocampal neu-
rons in AD, especially in neurons containing granulovac-
uolar degeneration. Interestingly, pPERK staining was
abundant in neurons that showed diffuse staining for
phosphorylated tau protein, whereas this staining was less
prominent in neurons containing neurofibrillary tangles.
The tangles themselves were not stained with pPERK. In
particular, in hippocampus the CA1, CA4, and subiculum
regions contained an abundance of pPERK-positive neu-
rons. UPR markers showed a granular staining pattern
that did not colocalize with ubiquitin or p62 protein,
indicating that they were not aggresomes. pPERK-positive
neurons also showed abundant staining for GSK-3β (gly-
cogen synthase kinase-3β). This is an important observa-
tion since it indicates that ER stress can activate the
expression of GSK-3β, a well-known tau kinase, and in
that way it could enhance neurofibrillary tangle formation
[42,43]. Unterberger et al. [44] have also observed that the
activations of PERK, eIF2α and p38 MAPK correlate with
the presence of abnormal tau in the neurons of AD
patients. These immunohistochemical studies have
revealed the close connection between the ER stress and
tau pathology in neurons. Moreover, they demonstrated
that UPR-positive staining is localized in neurons but not
in glial cells.
ER stress elicits inflammatory response
The UPR induced by ER stress involves both immediate
protein kinase responses and subsequent changes in the
expression of hundreds of target genes [15,16]. The pur-
pose of these adaptive effects is to restore cellular home-
ostasis. However, if the provoking stress is prolonged,
UPR can trigger the apoptotic cell death program inside
the cell. Recent studies have demonstrated that ER stress
can also generate signals which alert neighboring cells and
elicit an inflammatory response to prevent more extensive
tissue damage [7,45]. The ability of ER stress to induce an
inflammatory response is linked to the pathogenesis of
several diseases [46], e.g. obesity-induced ER stress can
trigger the inflammatory response and generate peripheral
insulin resistance [47]. Moreover, ER stress in liver can
activate systemic inflammatory response [22] and it is sug-
gested that ER stress can also induce autoimmune
responses [48].
The inflammatory reaction is normally generated by the
activation of pattern recognition receptors, e.g. TLRs (Toll-
like receptors) and NLRs (NOD-like receptors) which act
through signaling cascades, mostly via NF-κB system,
induce an inflammatory response [49,50]. Cells suffering
stress can also send alarmins which recruit and activate
immune cells [8,51]. For instance, neuron-glial interac-
tions involve several features which indicate that alarm
systems are present in neurodegenerative diseases (see
below). Recent studies have revealed that the transducers
of ER stress can also trigger signaling pathways which are
connected to the induction of inflammatory response.
Next, we will discuss the latest studies demonstrating that
the UPR is linked to the inflammatory response.
IRE1-XBP1 pathway
Activation of IRE1α triggers the expression of XBP1 pro-
tein which switches on the transcription of several UPR
genes but which can also stimulate phospholipid synthe-
sis and ER biogenesis [52]. Gargalovic et al. [53] demon-
strated that ER stress clearly induces the expression of IL6,
IL8, MCP1 (interleukins 6 and 8, monocytes chemoat-
tractant protein-1) and CXCL3 in endothelial cells. The
depletion of XBP1 mRNA with siRNA-techniques evokes a
significant inhibition in the expression level of these
inflammatory mediators [53]. Furthermore, Smith et al.
[54] reported that ER stress can strongly potentiate LPS
(lipopolysaccharide)-induced secretion of IFN-β in mac-
rophages. They observed that this response was depend-
ent on the expression of XBP1 protein, although the effect
is likely indirect since the promoter region of IFN-β gene
does not contain any XBP1 binding sites. On the other
hand, Kaser et al. [55] demonstrated that deletion of the
XBP1  gene can induce intestinal inflammation. The
genetic polymorphism of XBP1 observed in inflammatory
bowel disease also supports these results [55]. One couldJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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argue that these observations are contradictory to the role
of XBP1 in provoking inflammation but since XBP1 is a
major UPR inducer its deficiency will aggravate ER stress
and in that way trigger innate immunity defences.
Recently, Hetz et al. [56] demonstrated that deficiency of
XBP-1 protects against ALS, a devastating motor neuron
disease [57] which also involves the activation of innate
immunity [58]. Hetz et al. [56] used transgenic SOD1
mutant mice, a commonly studied mouse model of ALS.
They observed that deletion of XBP-1 increases the level of
autophagy, which reduces accumulation of aggregated
SOD1 proteins and in this way protects motor neurons.
However, a prolonged deficiency in UPR defence can be
detrimental and induce cell injuries and inflammatory
responses, as observed by Kaser et al. [55].
IRE1-TRAF2 pathways
In 2000, Urano et al. [17] demonstrated that the cytoplas-
mic domain of IRE1 can recruit the TRAF-2 transducer
protein, which can mediate several cellular functions, e.g.
apoptosis, inflammation, and metabolism [59,60]. Later,
it was observed that ASK1 (apoptosis signal-regulating
kinase 1) can bind to the complex of IRE1-TRAF2, and
ASK1 is an essential kinase in ER stress-induced neuronal
death [61]. ASK1 is a member of the MAPKKK family
which activates downstream both JNK and p38 MAP
kinases and thus induces neuronal apoptosis [62] (Figure
1). Several studies have shown that the IRE1-TRAF2 path-
way can activate NF-κB signaling [63-65]. Hu et al. [65]
demonstrated that the IRE1-TRAF2 complex recruits the
IKK (inhibitory-κB kinase) complex which binds to the
TRAF2 component of the complex. The activation of IRE1
in ER stress stimulates IKK kinases which subsequently
phosphorylate IκB proteins and trigger NF-κB signaling.
The TRAF2 transducer can interact with several other pro-
teins, e.g. TANK (a TRAF-binding protein) [66] and T2BP
[67] which can also trigger NF-κB signaling. The NF-κB
system is the major regulator of innate immunity
responses in several cell types [68], but JNK can also acti-
vate inflammatory responses via the AP-1 transcription
factor (activator protein-1) [69]. Interestingly, NF-κB sig-
naling inhibits the JNK activation [70] and prevents neu-
ronal apoptosis and tau pathology induced by the
activation of JNK [62,71].
PERK-eIF2α pathway
PERK is one of the stress kinases that can phosphorylate
eIF2α protein and thus inhibit protein synthesis [72].
Hypoxia, proteasomal inhibition and ultraviolet light also
inhibit protein synthesis via activation of the PERK-eIF2α
axis [73-75]. All of these treatments are well-known acti-
vators of NF-κB signaling. Deng et al. [76] demonstrated
that activation of NF-κB signaling correlates with reduced
levels of IκBα protein during inhibition of protein synthe-
sis. The turnover time of IκBα protein is shorter than those
of NF-κB components due to a PEST sequence in IκBα
protein [72,76]. This is probably a general mechanism
during stress since the NF-κB system has several survival
functions in host defence along with innate immunity
responses, e.g. the prevention of apoptotic cell death. NF-
κB signaling can repress expression of GADD153/CHOP
(growth arrest and DNA damage/CEBP homology pro-
tein), which is the major pro-apoptotic transcription fac-
tor induced by ER stress [77].
PERK-GSK-3 pathway
In addition to eIF2α, PERK has also other target proteins,
e.g. GSK-3 [78] (Figure 1). GSK-3 is an interesting kinase
in terms of AD pathology since it is believed to have a
major role in the pathogenesis of tau-pathology [41,43].
It has been known for many years that GSK-3β can acti-
vate NF-κB signaling and enhance inflammation while
lithium, a GSK-3 inhibitor, attenuates inflammatory reac-
tions. Beurel et al. [79] have recently reviewed the crucial
role of GSK-3 in the innate and adaptive immune
responses. GSK-3 can regulate the function of several
inflammation-associated transcription factors, e.g. NF-κB,
NFAT and AP-1, but this control is clearly context-depend-
ent [79]. Steinbrecher et al. [80] demonstrated that GSK-3
regulates in a gene-specific manner the recruitment of NF-
κB complexes to cytokine promoters. For instance, IL-6
and MCP-1 require the assistance of GSK-3β for efficient
transcription [80]. Demarchi et al. [81] observed that
GSK-3β can inhibit the processing of NF-κB/p105 into
mature p50 and thus repress NF-κB activation. It is known
that GSK-3β can enhance TWEAK (TNF-like weak inducer
of apoptosis)-mediated NF-κB activation in neuroblast-
oma cells [82]. TWEAK is believed to have a central role in
NF-κB activation and neuronal death in cerebral ischemia
[83].
ATF6/CREBH pathway
The ATF6 branch of ER stress transducers is not linked to
kinase signaling cascades, but trans-activates target gene
expression (Figure 1). There have been very few indica-
tions that ATF6 could regulate inflammatory genes. How-
ever, Zhang et al. [84] demonstrated that in liver ER stress
can activate the CREBH transcription factor which induces
expression of CRP (C-reactive protein) and SAP (serum
amyloid P-component). These acute-phase proteins are
well-known mediators of systemic inflammatory
responses. Zhang et al. [84] also claimed that activated
ATF6 could interact with cleaved CREBH protein and
potentiate acute-phase inflammatory responses. They also
observed that proinflammatory cytokines and LPS can
activate CREBH expression and in this way trigger a sys-
temic inflammatory response. Recently, Yamazaki et al.
[85] demonstrated that loss of the ER chaperone GRP78/
Bip activates ATF6-dependent Akt kinase phosphorylation
and subsequently triggers NF-κB signaling in NRK-52EJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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cells. It is likely that the ATF6/CREB family of transducers
has inflammatory responses but they are tissue-specific as
are many other functions of ATF6 (see above).
Inflammatory caspases
Inflammatory caspases are involved in the maturation of
the IL-1 family of cytokines in protein complexes called
inflammasomes [86]. This group of caspases consists of
caspase 1, 4, 5, 11 (only murine), and 12. Only caspase-4
and caspase-12 are activated by ER stress but their func-
tion in ER stress is still not defined [86,87]. Several studies
have indicated that activation of caspase-12 is related to
ER stress-induced apoptotic cell death (Figure 1). How-
ever, the activation mechanism is still unknown although
some putative mechanisms have been proposed, e.g. via
Ca2+ and Hip-2 signaling [88,89]. Wootz et al. [90] dem-
onstrated that XIAP (X-linked inhibitor of apoptosis) can
inhibit the activation of caspase-12 in spinal cord of ALS
transgenic mice. A greater discrepancy results from the
observation that there exists a polymorphism in the
human caspase-12 gene that leads to the appearance of
the active, ancestral full-length variant, and the inactive,
truncated form of caspase-12 in the population [87,91]. It
seems that carriers of truncated caspase-12 are more resist-
ant to severe sepsis [92]. The active caspase-12 isoform
attenuates inflammatory responses to endotoxin and thus
can increase the risk of sepsis. Recently, LeBlanc et al. [92]
demonstrated that caspase-12 inhibits activation of NF-κB
signaling by binding to the NOD-Rip2 complex, which
dislocates TRAF6 (TNFR-associated factor) from this com-
plex.
Human caspase-4 and caspase-5 are orthologs of mouse
inflammatory caspase-11 [86]. Caspase-4 is localized in
ER and is activated by the proteolytic cleavage. Several
studies have demonstrated that ER stress increases both
the expression level and cleavage of caspase-4 in different
experimental models [93-95]. Activation of caspase-4 can
trigger either apoptosis or an inflammatory response, or
both, depending on the cells involved and the experimen-
tal context (Figure 1). Further, caspase-4 is present in neu-
rons and neuronal stress can activate this caspase and
mediate apoptosis, e.g. in INCL (infantile neuronal ceroid
lipofuscinosis) and probably in AD [95,96]. The activa-
tion mechanism needs to be clarified but it is known to
require dimerization and interdomain processing [97]
and in that respect differs from the activation of caspase-1
in inflammasomes [50]. Lakshmanan and Porter [98]
observed that LPS-induced NF-κB activation is inhibited
in caspase-deficient human THP1 monocytes. They dem-
onstrated that LPS treatment induces binding of caspase-
4 with TRAF6 protein and this interaction mediates NF-κB
activation and subsequent cytokine secretion. TRAF-6 is
an important signal transducer between several innate
immunity receptors, e.g. Toll/IL-1 family, initiating NF-κB
activation via the IKK complex [99]. TRAF6 protein is
present in neurons and is known to mediate neurotrophin
receptor p75 signaling [100] and certain inflammatory
signals during hypoxia and reoxygenation in human NT2
neurons [101].
Ca2+-triggered pathways
ER stress disturbs cellular Ca2+ homeostasis and triggers
oxidative stress [12,102]. This type of cellular stress acti-
vates the host defence response which is obviously a cell-
specific reaction that includes inflammatory responses
and ultimately apoptotic cell death (Figure 1). Several
studies have indicated that Ca2+ is an important inducer of
NF-κB signaling both in ER stress [27] and in the physio-
logical activation of neurons [103]. IP3- (inositol triphos-
phate-) gated Ca2+ channels have a key role in calcium
regulation of neurons and are probably involved in AD
pathogenesis [104]. Schapansky et al. [105] demonstrated
that IP3-mediated Ca2+ release, stimulated by amyloid-β
exposure, increases the DNA-binding activity of the NF-κB
complex. Their results also indicated that activation of NF-
κB signaling can inhibit the expression of CHOP (C/EBP
homologous protein), a hallmark of ER-stress induced
apoptosis. They also observed that the NF-κB response
was even enhanced in presenilin 1-mutant neurons [105].
Nozaki et al. [77] revealed that NF-κB signaling can
repress expression of CHOP after different insults which
give rise to ER stress in breast cancer cells. It seems that the
NF-κB activation could represent a survival effect which is
linked to the UPR response. In neurons, NF-κB signaling
can mediate antiapoptotic responses, increasing the
expression of manganese SOD (superoxide dismutase),
IAPs (inhibitors of apoptosis), and calbindin [106].
ER stress: neuronal trigger for inflammation and 
AD pathology?
Neuronal ER stress: cause or consequence of AD?
Immunohistochemical studies have revealed that neurons
in postmortem brain samples of AD patients display
prominent expression of markers of ER stress, e.g. pPERK,
peIF2α and pIRE1α (see above). This is not a surprising
result since AD involves several characteristics that could
be inducers of ER stress, e.g. oxidative stress, accumula-
tion of neurofibrillary tangles and even intraneuronal
amyloid-β aggregates [1-3]. However, there is uncertainty
about whether this neuronal ER stress triggers inflamma-
tion and AD pathology or whether it is a consequence of
pathological processes in AD brain.
Genetic studies strongly indicate that amyloid-β produc-
tion, oligomerization and aggregation have a crucial role
in the pathogenesis of AD [1-5]. Recent studies have
revealed that oligomers especially are the toxic form of
amyloid-β in AD pathogenesis. One key question is
whether synthesized APP is cleaved in ER and in this way
could trigger amyloid-β oligomerization and subse-
quently an unfolding response in ER. BACE1 and γ-secre-Journal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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tase are present in ER but it seems that normally amyloid-
β is not cleaved in ER due to (i) the incompatible pH opti-
mum, (ii) the presence of BACE1 stabilizers, e.g. RTN3
and Nogo-B [107], and (iii) the protective acetylation of
BACE1 [108]. However, ER is a sensitive stress rheostat
that is affected by a number of environmental and cellular
insults. These can regulate the function of ER, e.g. by mod-
ulating expression of different chaperone molecules or by
regulating the capacity for cholesterol synthesis and pro-
tein modifications. For instance, Hoshino et al. [109]
demonstrated that increased ER chaperone levels can
inhibit the production of amyloid-β. In addition, ER stress
has been shown to increase the expression of BACE1 and
thus trigger APP processing in ER (see above). Annaert et
al. [110] have demonstrated that PS1 can control γ-secre-
tase activity in pre-Golgi compartments, and PS1 muta-
tions increase amyloid-β production in hippocampal
neurons of PS1 mutant mice. Ghribi [111] has speculated
on several factors that could affect amyloid-β processing
in ER, such as oxidative stress, disturbances in calcium
and cholesterol homeostasis, and trace metals.
ER stress and its effect on cholesterol synthesis can affect
trafficking of protein molecules through the ER-Golgi
pathway. It is known that seladin-1/DHCR24, a choles-
terol-synthesizing enzyme in ER, modulates APP process-
ing and amyloid-β production in vivo [112]. Greeve et al.
[113] demonstrated that seladin-1 can protect against
neurotoxicity induced by amyloid-β and oxidative stress.
Interestingly, seladin-1 expression is selectively down-reg-
ulated in the brain regions affected in AD [113,114]. Fur-
thermore, this reduced expression of seladin-1 is
associated with increased hyperphosphorylation of tau
protein and neurofibrillary tangles in AD brains [114]. A
genetic study also indicated that a polymorphism in the
seladin-1 gene could be associated with AD risk [115].
Recently, Sarajärvi et al. [116] demonstrated that down-
regulation of seladin-1 expression does not affect APP
processing in human SH-SY5Y cells over-expressing APP
under normal culture conditions. However, in apoptotic
conditions induced by staurosporin exposure, reduced
levels of seladin-1 clearly increase BACE1 level through
protein stabilization and subsequently enhanced cleavage
of APP to amyloid-β peptide. They also observed that
knock-down of seladin-1 expression in apoptotic condi-
tions triggers depletion of GGA3 protein, a Golgi-local-
ized BACE1-sorting protein, via caspase-3 cleavage.
Cerebral ischemia, a typical inducer of ER stress, also
induces depletion of GGA3 and increases BACE1 levels as
well as production of amyloid-β [117]. Golgi transport is
indispensable for APP processing, and inhibition of Golgi
transport, e.g. by treatment with brefeldin A, induces a
strong UPR [118]. Interestingly, during stress conditions,
APP appears to accumulate in ER or Golgi complex and in
this way could trigger ER stress [119].
It seems that ER stress can activate amyloid-β production
(see above) but, on the other hand, secreted amyloid-β
can also trigger ER stress [120]. There are clear indications
that ER stress inducers have synergistic effects on levels of
neuronal UPR, and ultimately can provoke apoptotic cell
death [e.g. [121]]. In this respect, it is not surprising that
there is evidence that viral infections may trigger AD
pathology, e.g. herpes simplex virus (HSV) [122,123].
Wozniak et al. [123] demonstrated that amyloid-β accu-
mulates in neurons infected by HSV and, unexpectedly,
they observed that HSV type 1 DNA is present in amyloid
plaques in AD brains. This dramatic observation still
needs verification. Recently, Ishikawa and Barber [124]
described an ER adaptor molecule, STING (stimulator of
interferon genes), which can recognize viral infections,
e.g. that of HSV, and activate innate immunity signaling
via NF-κB and IRF3 pathways. The activation of STING
induces expression of type I interferons, IFN-α and IFN-β,
which have both beneficial and pathological effects in
CNS, e.g. the overexpression of IFN-α in transgenic mice
induces neurodegeneration with loss of cholinergic neu-
rons, gliosis and angiopathy [125], which are also charac-
teristics of AD brain. Another example of the synergistic
accumulation of ER stress could be the boxing related dis-
order dementia pugilistica [126]. Neurotrauma is a pow-
erful inducer of ER stress, and UPR in CNS injuries [127]
could trigger AD via repeated ER stress. Ischemia and
hypoxia also induce ER stress and subsequently neuronal
cell death [128]. Such pathogenic mechanisms in AD, e.g.
those caused by cerebral amyloid angiopathy and micro-
haemorrhages, could be aggravated by sustained ER stress.
In conclusion, it seems that ER stress can disturb APP
processing in neurons, act synergistically with other
inducers to stimulate UPR in neurons, and subsequently
provoke AD pathology in the context of prolonged stress.
On the other hand, AD is known to involve several path-
ological changes that can trigger ER stress and in that way
aggravate AD pathogenesis. However, neither inflamma-
tory disorders of the CNS nor frontotemporal tauopathies
induce AD pathology, which suggests that amyloid-β has
a specific role in AD pathogenesis.
Neuronal ER stress: inducer of inflammation and 
ADpathology?
It is obvious that ER stress in neurons can be a crucial fac-
tor in the pathogenesis of AD. Activation of the innate
immunity system and the appearance of inflammatory
responses are closely involved in AD pathology [129]. As
described above, there are several pathways associated
with UPR that can trigger inflammatory responses as well
as apoptotic cell death. There is emerging evidence that
the aforementioned inducers of inflammation can be trig-
gered inside of neurons provoked by UPR, as occurs in
several other cell types. Generally, it is believed thatJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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inflammation is a secondary response to secreted amy-
loid-β oligomers and neuronal cell death. In addition, the
role of ER stress as a causative factor of sublethal neuronal
damage in AD needs to be addressed.
Innate immunity is a host defence system in tissues, prin-
cipally the responsibility of specialized immune cells, e.g.
microglial cells in the brain. Innate immunity can recog-
nize PAMPs (pathogen-associated molecular patterns)
and DAMPs (damage-associated molecular patterns) via
PRRs (pattern recognition receptors), such as TLRs and
inflammasomal receptors. We have recently reviewed the
activation mechanisms of innate immunity in AD brain
[129,130]. Several alarmins, i.e. messenger molecules
mediating a signal of imminent danger, have been identi-
fied [8]. It is obvious that neurons can send alarming sig-
nals if there is an aggravating ER stress. Neurons also
contain a large set of PRRs [129-131] of which the most
interesting may well be the inflammasomal receptors, e.g.
NALP1, which can activate inflammatory caspases [see
our review [130]]. Several alarmins, e.g. HMGB1 [132]
and S100 [133] proteins, are also expressed in neurons. A
number of studies have demonstrated that during stress,
neurons can express and secrete both cytokines and chem-
okines [e.g. [134-141]]. Chemokines, e.g. CX3CL1, CCL2,
and CCL21, are important alarm molecules in neurons
since, after secretion, they can activate glial chemokine
receptors [134,135]. Chemokines are versatile messengers
mediating neuron-glial cell interactions, e.g. they can reg-
ulate the proliferation and migration of astrocytes and
microglia [134]. However, it seems that neuronal chem-
okines have both neuroprotective and neurotoxic effects
on glial cells.
Neuronal cells can also express and secrete cytokines, e.g.
IL-6 [e.g. [136,137]] and TNF-α [138,139], and even com-
plement factors [140,141]. Recently, He et al. [142] dem-
onstrated that deletion of TNFR1, a TNF-α responding
receptor, can inhibit amyloid-β generation and prevent
cognitive deficits in AD mice. This deletion reduced the
expression and activity of BACE1 by blocking NF-κB sign-
aling. Such transgenic mice also exhibit a decline in
microglial activation and neuronal loss. Janelsins et al.
[139] observed that chronic overexpression of neuronal
TNF-α enhances local inflammatory responses in trans-
genic AD mice. However, there are also reports that the
pro-inflammatory cytokine TNF-α has neuroprotective
effects in the brain [143].
The NF-κB transcription factor system is the major signal-
ing pathway evoking the inflammatory responses [68].
NF-κB signaling can also prevent apoptotic signals by
inhibiting JNK signaling and stimulating the expression of
IAP (inhibitor of apoptosis) proteins [70,144]. ER stress
induces several pathways which can activate NF-κB signal-
ing, (i) IRE1-TRAF2-IKK pathway, (ii) PERK-eIF2α activa-
tion, (iii) PERK-GSK-3 activation, and (iv) Ca2+-triggered
pathways. There are clear indications that these pathways
can induce inflammatory responses via NF-κB signaling in
many different cell types (see above). In neurons, the acti-
vation of the NF-κB system is associated with several func-
tions, e.g. neuronal survival and plasticity [145] but also
with the signaling of some PRRs [129]. Ridder and Schwa-
ninger [146] have reviewed the role of NF-κB signaling in
cerebral ischemia. In AD, NF-κB signaling can enhance
BACE1 expression and thus increase amyloidogenesis
[147]. However, prolonged activation of NF-κB signaling,
either via ER stress or inflammatory cytokines, e.g. TNF-α,
can repress NF-κB signaling. Several studies have demon-
strated that persistent ER stress can inhibit inflammatory
responses by down-regulating IRE1-TRAF2-mediated IKK
activation [65,148]. There are several other autoregulatory
feedback loops involved in terminating NF-κB signaling
[149]. It seems that neurons can protect themselves
against overwhelming NF-κB activation by expressing
Sp1-related transcription factors, which can bind to a sub-
set of κB sites and inhibit expression of distinct target
genes [150]. The expression levels of Sp3 and Sp4 factors
are increased in AD brains, in particular in neurons con-
taining tau tangles [151]. Several negative feedback sys-
tems imply that NF-κB is an important regulator in
neuronal degeneration, either in inflammation or apopto-
sis.
Inflammatory caspases located in ER, i.e. caspase-4 and
caspase-12 in humans, are another major pathway that
can trigger inflammatory responses and apoptosis associ-
ated with ER stress (Figure 1, see above). As described ear-
lier, PS1, a co-regulator of γ-secretase, is present in the ER
and can control the processing of APP to amyloid-β in the
ER [152]. Recently, Rechards et al. [153] demonstrated
that PS1 is located in COPI-coated membranes in pre-
Golgi compartments. Yukioka et al. [154] observed that
AD-linked PS1 mutation can trigger the cleavage of cas-
pase-4 and subsequently activate caspase-3 and caspase-9.
This is an interesting observation since caspase-3 can
cleave tau protein and induce tangle pathology [155]
whereas caspase-4 itself is unable to cut tau protein [155].
Moreover, several other studies have demonstrated that
exposing cells to amyloid-β induces activation of both cas-
pase-4 and caspase-12 [89,96]. In the case of caspase-12,
the amyloid-β-induced activation seems to be mediated
by Hip-2 protein [89]. Moreover, in AD there seems to be
a negative feedback to caspase-4 activation. The amy-
loidogenic APP cleavage releases AICD (APP intracellular
domain) and its interacting partner, FE65 transcription
factor, which subsequently can translocate to the nucleus.
Kajihara et al. [156] demonstrated that this AICD-FE65
complex can bind to the promoter region of caspase-4.
They also observed that FE65 factor interacts with Teashirt
protein, which recruits histone deacetylases and thus
inhibits the transactivation of caspase-4. Teashirt is anJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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abundant protein in neurons. This indicates that neurons
can prevent prolonged, amyloid-β-induced activation of
caspase-4 and consequent inflammatory and pathological
responses in AD.
The IRE1α-TRAF2-ASK1 pathway activates stress kinases
[16,17] which have profound functional effects on neuro-
nal homeostasis [19,59,62]. ER stress activates ASK1,
which subsequently can trigger JNK and p38 MAPK sign-
aling. However, it is still an open question whether ER
stress is the only inducer of ASK1. For instance, Kadowaki
et al. [157] observed that amyloid-β induces neuronal
apoptosis through ROS-mediated ASK1 activation rather
than via ER stress. However, ER stress can trigger ROS pro-
duction via Ca2+ mitochondrial signaling. ASK1-mediated
JNK activation has great potential to provoke the patho-
genesis of AD [158]. This stress kinase signaling can (i)
regulate APP processing and induce accumulation of
intracellular amyloid-β [159,160], (ii) phosphorylate tau
protein and trigger aggregation of neurofibrillary tangles
[161,162], and (iii) potentiate inflammatory responses
via AP-1 activation [18]. In their histopathological study
of AD brains, Lagalwar et al. [71] observed that activated
pJNK accumulates in granules within hippocampal
pyramidal cells. These granules frequently co-localize
with granulovacuolar degeneration bodies (GVD) [71]
which also contain GSK-3β [163], a well-known PERK tar-
get kinase (see above). GVD are large cytoplasmic vacu-
oles [71] which are reminiscent of the autophagic
vacuoles commonly observed in AD [164]. Interestingly,
several studies have demonstrated that excessive ER stress
can induce autophagic uptake of accumulated material
from the overloaded ER [165]. Activated pJNK and pGSK-
3β are also present in pretangle accumulations of tau pro-
tein [166,167], which are different structures from GVDs.
Sahara et al. [168] demonstrated that JNK can induce cas-
pase cleavage of tau protein but also that GSK-3β activa-
tion is required for tau aggregation.
ER stress can cause Ca2+ efflux from ER and its accumula-
tion in mitochondria. An increased intracellular concen-
tration of Ca2+ induces several pathological responses,
observed also in AD [40,169]. However, it is difficult to
distinguish the specific role of ER stress in Ca2+-induced
disturbances in pathological conditions. It seems that
maintenance of Ca2+ balance is important since there are
Ca2+-sensitive modulators that can switch off stress-
related signaling pathways. For instance, CIB1 (calcium
and integrin binding protein 1) can bind to ASK1 and
inhibit its interaction with TRAF2 [170] which blocks the
stress-activated MAPK signaling pathway. Another is cal-
nuc (nucleobindin 1) which can inhibit ATF6 activation
in ER stress [171]. Calnuc, a Ca2+-binding protein in the
Golgi complex, interacts with APP and regulates its
processing [172]. Overexpression of calnuc inhibits APP
expression and amyloid-β production whereas its down-
regulation increases cellular levels of APP. Interestingly,
levels of calnuc are significantly decreased in AD brains
[172] and this could potentiate amyloid-β production.
Neuronal-glial interactions are important regulators of
inflammation and AD pathology. In AD, it seems that ER
stress is a greater threat to neurons than glial cells since
UPR is more pronounced in neurons than glial cells (see
above). Moreover, ER stress induces in neurons the pro-
duction of alarmin-type of molecules, e.g. chemokines
and cytokines, which affect the function of glial cells. In
particular, neuronal chemokines are important messenger
molecules between neurons and glial cells [134,135].
Mott et al. [173] observed that neurons can secrete CD22
protein, which inhibits proinflammatory cytokine pro-
duction in microglia. Other studies have also demon-
strated that neurons can suppress microglial activation
[174]. This is a logical way to prevent the overactivation of
microglia during stress conditions but this immunotoler-
ance may impact detrimentally on microglial cleansing
capacity and permit the aggregation of senile plaques. On
the other hand, ER stress and UPR may have beneficial
feedback effects since ER stress can induce expression of
NF-κB inhibitors, e.g. A20, which is known to generate
immunotolerance to certain non-immune cells [148] as
well as to suppress the deleterious effects of excessive UPR.
Conclusions
There are clear indications that ER stress is involved in the
pathogenesis of AD. Many of the pathological characteris-
tics of AD, e.g. oxidative stress, impaired Ca2+ homeosta-
sis, intracellular deposition of tau proteins and amyloid-β
peptides, may be caused by ER stress in neurons but, on
the other hand, this kind of pathology can also trigger ER
stress and thus aggravate AD pathology. The markers of ER
stress in AD are located in neurons rather than in glial
cells. This observation is in agreement with the amyloid
hypothesis of AD since misfolded and aggregated proteins
are a quality problem in neurons and can trigger cellular
defence through UPR. The purpose of this response is to
slow down protein synthesis and increase protein folding
capacity by increasing the levels of ER and cellular chaper-
ones. In addition, UPR can strengthen the redox defence
and buffering capacity of Ca2+, and potentiate cellular
cleansing by autophagy. ER stress can also prepare neu-
rons to undergo apoptotic cell death. Interestingly, recent
studies have indicated that ER stress can also trigger
inflammatory responses to defend brain tissue against
necrotic injuries. This response seems to be an alarm type
of response involving chemokines and cytokines to acti-
vate glial cells.
Excessive and/or prolonged ER stress can be detrimental
to neurons since a delayed defence decreases the viability
of neurons and can shift the UPR response to switch on an
apoptotic program. However, the ER is highly specializedJournal of Neuroinflammation 2009, 6:41 http://www.jneuroinflammation.com/content/6/1/41
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in neurons and the level of ER stress can vary among dif-
ferent subcompartments, e.g. in dendrites and axonal syn-
apses. Initial evidence indicates that ER stress can trigger
synaptic loss and axonal degeneration. In conclusion, ER
stress involves all the elements that can aggravate the
pathogenesis of AD.
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